First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model

• Główni autorzy: Jinliang Chen (Autor), Zourong Ruan (Autor), Honggang Lou (Autor), Dandan Yang (Autor), Rong Shao (Autor), Yichao Xu (Autor), Xinhua Hu (Autor), Bo Jiang (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Salvianolic acid A (SAA) is a water-soluble phenolic acid component from Salvia miltiorrhiza Bunge currently under development for myocardial protection treatment for coronary heart disease (CHD). We investigated the safety, tolerability, and pharmacokinetics of single and multiple ascending doses o...